You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仙琚製藥(002332.SZ):擬公開掛牌轉讓梓晶生物15%的股權
格隆匯 10-17 12:48

格隆匯10月17日丨仙琚製藥(002332.SZ)公佈,杭州梓晶生物有限公司(“梓晶生物”)系公司參股公司,設立於2021 76日,註冊資本500萬元人民幣,公司目前持有其49%股權。考慮到梓晶生物的長遠發展需要,為吸引團隊和引入專業機構,優化其股權結構公司擬按照國有資產處置程序,通過公開掛牌方式,以不低於標的股權評估值轉讓梓晶生物15%的股權。

次轉讓梓晶生物股權有利於進一步優化梓晶生物股權結構,有利於梓晶生物的長遠發展。此次股權轉讓完成後,不涉及公司合併報表範圍變更,公司對梓晶生物的持股比例將由目前的49%降至34%,不會對公司財務狀況及經營成果產生重大影響,也不存在損害公司及股東特別是中小股東利益的情形。董事會授權經營層辦理後續股權掛牌及轉讓相關事宜。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account